Investment adviser · CRD 329146
LEGACY PHARMA INVEST GP INC.
Exempt reporting adviser (ERA)
Exempt reporting advisers use a shorter Form ADV report. Some adviser-level figures are not reported; fund disclosures appear below when available.
TORONTO, ON, Canada · Form ADV filed Mar 27, 2026
Adviser-level assets, account counts and staffing figures are unavailable in this filing. View the reported fund disclosures below →
Private funds & service providers
1 Private fundThe count excludes feeder funds. Funds in the latest filing appear first, ordered by reported gross assets. Earlier funds retain their last reported values.
LEGACY PHARMA INVEST LPPrivate Equity Fund · Last reported Mar 27, 2026$25MGross asset value
Form D fundraising filings
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- Yes
- External marketing
- No
KPMG LLP
PCAOB 85
Fund details & source
- Fund ID
- 805-4107105431
- Reported beneficial owners
- 22
- Minimum commitment
- $0
- Form D file number
- 021-495554
Form ADV 2074967 · Mar 27, 2026 · Schedule D 7.B.(1)
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
Services & filing details
Most recent filing: Mar 27, 2026. View historical filings
Reported services
Not reported in these imported fields
Compensation
Not reported in these imported fields
Principal office
141 ADELAIDE ST. W, SUITE 515TORONTO, ON, M5H 3L5, Canada
CRD 329146
Filing source
Form ADV 2074967 · Mar 27, 2026 · Items 1 & 5
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.